Using Vanrx Workcells, pharmaceutical companies can bring injectable medicines to market faster. Short changeover times and flexible systems enable agile manufacturing.
Vanrx Pharmasystems’ Microcell Vial Filler has won the ‘Best in Show’ award at Interphex 2018, which "recognizes accomplishments and display in the use of knowledge, innovation, and state-of-the-art technologies to achieve extraordinary levels of quality, production goals, and objectives—ultimately transforming critical and affordable life-enhancing ideas to finished drug products.”Read More
Vanrx Pharmasystems and SiO2 Medical Products, Inc. (SMP) are announcing that SMP is joining the Matrix Alliance. The company's 2, 6, and 10 mL vials incorporate new coating technology, readily integrate into Vanrx filling machines, and are compatible with the closure systems of Matrix Alliance companies.Read More
Patheon, an international CDMO, recently published a case study of its experience installing an SA25 Aseptic Filling Workcell at one of its U.S. sites. To address the issue of human involvement in the filling process, the company successfully implemented a robotic filling line that operates in a closed isolator environment with no glove ports. This case study takes a look at the technology involved and highlights the implementation team’s experience with installation and qualification.Read the case study
The new white paper Aseptic Filling for Personalized Medicines describes a new solution for the aseptic filling of cell and gene therapies, immuno-oncology, mRNA and other modalities where manufacturing creates a therapy for a single patient.
A new gloveless robotic isolator for aseptic filling is particularly cost-effective and agile, helping companies process multiple patients per day within a single machine.Download the white paper
Jun 5 - Jun 7, 2018
Boston, MA, USA
Jun 14 - Jun 15, 2018
San Francisco, CA, USA
Sep 4 - Sep 7, 2018
Boston, MA, USA
Get a detailed view of how Aseptic Filling Workcells compare to conventional technologies and help bring drug products to market faster.Download the white paper
Our team members have developed and brought complex drug products to market. We know what you need now, and are designing for the future.